LICENSE AGREEMENTLicense Agreement • January 19th, 2022
Contract Type FiledJanuary 19th, 2022This License Agreement (“Agreement”) is entered into as of August 12, 2019 (the “Effective Date”) by and between Novartis International Pharmaceutical AG, a for profit corporation with its principal place of business at Lichtstrasse 35, CH-4056 Basel, Switzerland (“Novartis”), and Pharming Group N.V., a Netherlands for profit corporation with its principal place of business at Darwinweg 24, Leiden 2333 CR, The Netherlands (“Pharming”).
LICENSE AGREEMENTLicense Agreement • November 25th, 2020 • Pharming Group N.V. • Pharmaceutical preparations
Contract Type FiledNovember 25th, 2020 Company IndustryThis License Agreement (“Agreement”) is entered into as of August 12, 2019 (the “Effective Date”) by and between Novartis International Pharmaceutical AG, a for profit corporation with its principal place of business at Lichtstrasse 35, CH-4056 Basel, Switzerland (“Novartis”), and Pharming Group N.V., a Netherlands for profit corporation with its principal place of business at Darwinweg 24, Leiden 2333 CR, The Netherlands (“Pharming”). Novartis and Pharming are each referred to individually as a “Party” and together as the “Parties.”